Understanding CBD
Reviewed by executive management. September 16, 2026. Scientific review pending.
CBD is one of many cannabinoids produced by cannabis. Products containing CBD vary in dose, formulation, ingredients and quality. Evidence about one product or dose does not automatically apply to another.Source: U.S. Food and Drug Administration. FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD). Last checked: .
Important evidence context. Micelle 60 and FDA-approved prescription cannabidiol are separate products. No clinical, pharmacokinetic, exposure, efficacy, safety or comparability bridge has been established between them. Micelle 60 is not FDA approved, and no clinical benefit or product-specific safety profile has been established for it.
How we review this information
These pages are reviewed and approved by executive management and have been submitted to our Chief Scientific Officer for scientific review. Each page will show her name and the date once she has signed it. Each claim-bearing page identifies its sources, evidence limitations and the date the evidence was last checked. Draft or incomplete pages remain unpublished.
Explore this section
- What CBD is
- How to assess evidence about CBD
- Talking with your care team
- How to read a certificate of analysis
- How access works
- Older adults and people taking several medicines
- During cancer treatment
- For family members and caregivers
One fact to know first
FDA has approved one prescription drug containing purified CBD for specified seizure disorders. That approval applies only to that drug and its labeled uses. It does not apply to Micelle 60 or to CBD products generally. Participation in a CMS Innovation Center incentive does not change a product’s FDA status.Source: U.S. Food and Drug Administration. FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD).; Jazz Pharmaceuticals, Inc. EPIDIOLEX® (cannabidiol) oral solution: Full Prescribing Information. Revised May 2026. DailyMed, U.S. National Library of Medicine.; Centers for Medicare & Medicaid Services. Substance Access Beneficiary Engagement Incentive. Last checked: .
For questions about your own health, speak to your care team.
Sources: [1]. Evidence last checked September 16, 2026.Source: U.S. Food and Drug Administration. FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD). Last checked: .